Coordinating Data Monitoring Committees and Adaptive Clinical Trial Designs Jay Herson Statistics 30 December 2008 Pages: 297 - 301
Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials Craig H. MallinckrodtPeter W. LaneJames P. Mancuso Statistics 30 December 2008 Pages: 303 - 319
Current Statistical Requirements for Pharmaceutical Clinical Trials in China Feng ChenQiguang ChenJason Hsu Statistics 30 December 2008 Pages: 321 - 330
Adaptive Design and Decision Analysis—Companions for Transforming Clinical Development Andreas Sashegyi Statistics 30 December 2008 Pages: 331 - 336
Conditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments with One Control Group Seung-Ho KangSuktae Choi Statistics 30 December 2008 Pages: 337 - 347
Preparing Regulatory Submissions with the FDA Reviewer in Mind: Use of the Clinical Review Template and Clinical Safety Reviewer Guidance by Sponsors Mary VanderhoofMichael J. UmenDavid N. Schwartz Clinical 30 December 2008 Pages: 349 - 357
Evaluation of Some Alternative Designs for Phase 2 Multiple Sclerosis Trials—A Simulation Study Ulrike HeldKarina SteyerMartin Daumer Clinical 30 December 2008 Pages: 359 - 367
Regulatory Requirements and Informed Consent Michael R. Hamrell Informed Consent 30 December 2008 Pages: 371 - 373
Consent Comprehension in the 21st Century: What is Missing? Mark Hochhauser Informed Consent 30 December 2008 Pages: 375 - 384
Consent Forms, Lower Reading Levels, and Using Flesch-Kincaid Readability Software Kris A. WaltersMichael R. Hamrell Informed Consent 30 December 2008 Pages: 385 - 394
2008 Annual Meeting Student Poster Abstracts Springer 2008 Annual Meeting 30 December 2008 Pages: 395 - 400
